naltrexone has been researched along with carbamates in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Booker, L; Cravatt, BF; Lichtman, AH; Naidu, PS | 1 |
Ayestas, M; Bilsky, EJ; Dersch, CM; Deveau, AM; Pelotte, AL; Rothman, RB; Smith, RM | 1 |
Ma, L; Pei, G; Teng, L; Wang, F; Zhao, J | 1 |
Annaert, PP; Atack, JR; Borghys, H; de Vries, R; De Zwart, LL; Embrechts, RC; Gaekens, T; Guillaume, M; Herdewijn, P; Leysen, JE; Megens, AA; Vermeulen, A | 1 |
Hussar, DA | 1 |
5 other study(ies) available for naltrexone and carbamates
Article | Year |
---|---|
Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
Topics: Acetic Acid; Amidohydrolases; Animals; Benzamides; Carbamates; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Protective Agents; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stomach Ulcer | 2009 |
Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypes.
Topics: Animals; Carbamates; Cell Line; CHO Cells; Cricetinae; Cricetulus; Drug Design; Humans; Naltrexone; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sulfuric Acid Esters; Transfection | 2009 |
A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Carbamates; Cells, Cultured; Dipeptides; Enkephalin, Leucine-2-Alanine; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multiprotein Complexes; Naltrexone; Narcotic Antagonists; Protein Transport; Receptors, G-Protein-Coupled; Receptors, Opioid, delta; Substrate Specificity; Transport Vesicles | 2010 |
Lipophilic nalmefene prodrugs to achieve a one-month sustained release.
Topics: Animals; Carbamates; Delayed-Action Preparations; Dogs; Fatty Acids; Female; Glutarates; Male; Naltrexone; Narcotic Antagonists; Prodrugs; Swine; Swine, Miniature | 2016 |
New Drugs 2018, part 1.
Topics: Aminoisobutyric Acids; Antibodies, Monoclonal; Antibodies, Neutralizing; Antipyrine; Benzamides; Benzimidazoles; Broadly Neutralizing Antibodies; Carbamates; Cyclopropanes; Drug Approval; Drug Combinations; Edaravone; Heterocyclic Compounds, 4 or More Rings; Humans; Lactams, Macrocyclic; Leucine; Macrocyclic Compounds; Naltrexone; Natriuretic Peptides; Proline; Pyridines; Pyrrolidines; Quinoxalines; Sofosbuvir; Sulfonamides; United States; United States Food and Drug Administration | 2018 |